Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-19-000718
Filing Date
2019-08-21
Accepted
2019-08-21 09:45:16
Documents
1
Period of Report
2019-08-19

Document Format Files

Seq Description Document Type Size
1 matinasbio_fm4aug192019.html 4  
1 matinasbio_fm4aug192019.xml 4 8066
  Complete submission text file 0000905718-19-000718.txt   9453
Mailing Address STERN AEGIS VENTURES 810 7TH AVENUE 22ND FLOOR NEW YORK NY 10019
Business Address
STERN ADAM K (Reporting) CIK: 0001403497 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38022 | Film No.: 191041378

Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Issuer) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations